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Synaptic vesicles are storage organelles for neurotransmitters. They pass through a traf-
ficking cycle and fuse with the pre-synaptic membrane when an action potential arrives at the
nerve terminal. While molecular components and biophysical parameters of synaptic vesicles
have been determined, our knowledge on the protein interactions in their membranes is
limited. Here, we apply cross-linking mass spectrometry to study interactions of synaptic
vesicle proteins in an unbiased approach without the need for specific antibodies or
detergent-solubilisation. Our large-scale analysis delivers a protein network of vesicle sub-
populations and functional assemblies including an active and an inactive conformation of the
vesicular ATPase complex as well as non-conventional arrangements of the luminal loops of
SV2A, Synaptophysin and structurally related proteins. Based on this network, we specifically
target Synaptobrevin-2, which connects with many proteins, in different approaches. Our
results allow distinction of interactions caused by ‘crowding’ in the vesicle membrane from
stable interaction modules.
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S ignal transmission between neurons is mediated by exocytosisof neurotransmitters and takes place at specifically designedcontact sites called synapses1. In the pre-synaptic nerve
terminal, neurotransmitters are stored in synaptic vesicles. They are
released from the vesicles into the synaptic cleft where they are
received by neurotransmitter receptors of the post-synaptic mem-
brane. To allow rapid and directed neurotransmitter release,
synaptic vesicles undergo a trafficking cycle which prepares them
for repeated rounds of exocytosis2. The synaptic vesicle cycle starts
with neurotransmitter uptake operated by neurotransmitter-specific
transporters. These transporters are fuelled by the proton-
electrochemical gradient established by a vesicular proton pump
with ATPase activity (termed ‘V-ATPase’)3,4. After neuro-
transmitter loading, synaptic vesicles form a readily releasable pool
of docked vesicles at the active zone of the pre-synaptic terminal5.
Docked vesicles are then activated in a process called ‘priming’6.
Upon intracellular Ca2+ influx as a response of an action potential,
the vesicle and pre-synaptic membranes fuse and neurotransmitters
are released7,8. Synaptic vesicles are retrieved from the plasma
membrane following alternative pathways, including clathrin-
mediated endocytosis or transient pore formation and subsequent
pore closure (‘kiss-and-run’)9.
First and foremost, synaptic vesicles are storage organelles for
neurotransmitters. However, in addition to the neurotransmitter
loading machinery, they are densely packed with proteins that
orchestrate the many interactions formed during the synaptic
vesicle cycle and fulfil the required functional tasks. Membrane
fusion, for instance, is realised by SNARE (i.e. soluble N-ethyl-
maleimide-sensitive-factor attachment receptor) complex forma-
tion including interactions between Syntaxin-1A and SNAP25 on
the pre-synaptic membrane and Synaptobrevin-2 on the vesicular
membrane10. For this, Syntaxin-1A and Synaptobrevin-2 both
contribute one and SNAP25 two α-helices to the stable four-helix
bundle of the assembled SNARE complex11. In addition to the
core fusion machinery, there are several regulatory factors which
are anchored in the respective membranes or are components of
the synaptic cytosol12. An example is the vesicular calcium sensor
Synaptotagmin-1, which binds negatively charged phospholipids
as well as the SNARE complex suggesting different regulatory
modes of action13.
To unravel the complexity of synaptic vesicles, several studies
targeted the proteomes of purified synaptic vesicles14–16 as well as
specific states such as docked17 or clathrin-coated vesicles18 or
GABAergic and glutamergic sub-populations19. These studies
revealed a set of synaptic vesicle core components; however, the
functional role of many vesicle proteins remains elusive. Quan-
titative studies then delivered copy numbers of vesicular proteins
and provided a first glimpse into the organisation of the crowded
vesicle membrane15,20 and its synaptic environment21. Accord-
ingly, Synaptobrevin-2 represents the major protein component
with up to 70 copies per vesicle. Additional abundant vesicle
components are Synaptophysin, Synaptotagmin-1 and Synapsin-
1. In contrast, only one or two copies of the V-ATPase complex
are anticipated in synaptic vesicles15,20.
Despite the progress in unravelling the synaptic vesicle pro-
teome, we have only little knowledge on the protein interactions
formed between synaptic vesicle components at the different
stages of the synaptic vesicle cycle. Apart from the SNARE
complex, for which high-resolution structures are available11,22,
our knowledge mostly relies on binary or ternary interactions
identified in biochemical assays. A frequent target of such studies
were the two vesicle markers Synaptobrevin-2 and Synaptophy-
sin. Chemical cross-linking and subsequent immunoblotting
revealed oligomerisation of Synaptophysin23–25 as well as a stable
complex between the two proteins26. These interactions were
further investigated by electron microscopy suggesting a 1:2
(Synaptophysin:Synaptobrevin-2) stoichiometry in a hexameric
complex27,28. Immunoprecipitations from synaptosome extracts
further revealed interactions between Synaptophysin/Synapto-
brevin-2 and the membrane-sector VO of the V-ATPase29 as well
as several detergent-sensitive interactions between SV2A,
Synaptotagmin-1, Synaptophysin and Synaptobrevin-230. Recent
studies targeted intact synaptosomes and provided a three-
dimensional model of an ‘average’ synapse21 as well as protein
interaction networks31. However, a detailed study on purified
synaptic vesicles is still missing. One possible reason is the het-
erogeneity of synaptic vesicle populations making them challen-
ging targets for structural biology techniques.
Here, we overcome these difficulties by combining chemical
cross-linking and mass spectrometry (MS) with biochemical and
biophysical tools to unravel the protein interactions of purified
synaptic vesicles. In a first set of experiments, we present an inter-
action network of synaptic vesicle proteins revealing different co-
existing functional assemblies. We specifically target the V-ATPase
complex and identify two conformations, the active, fully assembled
enzyme and the dissociated, inhibitory VO-ATPase. We then follow
different approaches to unravel the interactions of co-existing sub-
networks and provide insights into specific and stable interaction
modules. In particular, the fusion of synaptic vesicles with ‘empty’
liposomes reveals specific protein interactions formed in a spacious
membrane environment allowing their distinction from unspecific
interactions formed in the naturally crowded vesicle membrane.
Results
Proteome assessment of synaptic vesicles purified from rat
brain. We set out to study protein interactions in synaptic vesicles
using chemical cross-linking and MS. To allow unambiguous
assignment of proteins in these large-scale experiments, we first
evaluated five independent preparations of synaptic vesicles. For this,
synaptic vesicles were purified from rat brain following established
protocols15,32,33. Figure 1a shows a gel of a typical vesicle prepara-
tion. Negative stain electron microscopy further confirmed integrity
of the vesicles (Fig. 1b and Supplementary Fig. 1). Proteins separated
by gel electrophoresis were hydrolysed using endoproteinase trypsin
and obtained peptides were analysed by liquid chromatography-
coupled tandem-MS (LC-MS/MS). Gel electrophoresis and LC-MS/
MS analysis confirmed that different vesicle preparations are com-
parable (Supplementary Fig. 2). In total, when applying a false-
discovery rate (FDR) of 1%, we identified >1000 proteins with high
scores (Supplementary Data 1 and Methods) including all previously
identified synaptic vesicle proteins14–16 as well as typical con-
taminants. We further used intensity-based absolute quantification
(iBAQ)34 to evaluate protein abundances. For this, the sum of
peptide intensities corresponding to one protein is normalised by the
number of theoretically observable peptides. The relative iBAQ then
represents the relative proportion of each protein in the sample and
allows the estimation of protein stoichiometries. As expected, all
major synaptic vesicle components are amongst the high abundant
proteins (Supplementary Data 1).
We first inspected the V-ATPase complex which represents an
individual multi-subunit protein complex embedded in the vesicle
membrane and represented on its cytosolic side. A recently
published high-resolution structure from rat brain revealed the
exact composition and arrangements of protein subunits in the
soluble V1- and the membrane-embedded VO-domains35. Our
proteomics analysis confirmed the presence of 15 of the 16 reported
subunits including isoforms of subunits B, E, G, C, a and d
(Supplementary Data 2). Subunit e/e2 does not contain a sufficient
number of tryptic cleavage sites and is therefore missing in our
analysis. Subunits (isoforms) B1, C2, a4, c”, d2, f and Ac45 were
only identified with low scores and therefore failed our stringent
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selection criteria (see ‘Methods’). Subunit c” was to-date only
confirmed in the recent high-resolution structure35. Due to a low
number of tryptic cleavage sites, we identified only one tryptic
peptide in one of five preparations (Supplementary Data 2).
Importantly, subunit H, which is required for full activity of the
enzyme36 but was missing in the recent structure35, was identified
in our analyses with high scores and sequence coverage
(Supplementary Data 1 and 2) confirming the quality of our vesicle
preparations.
Having confirmed the presence of the intact V-ATPase, we
used the ratio of iBAQ intensities for assessing protein
stoichiometries. With one exception (subunit G1/G2), the
expected stoichiometry of A3B3E3G3D1F1C1H1 was observed for
the V1-domain (Fig. 1c). Stator subunit G1/G2 was under-
represented when compared with its binding partner E1 and core
subunits A and B2. Close inspection of the amino acid sequence
revealed an atypical distribution of tryptic cleavage sites likely
affecting iBAQ analysis which is based on the number of
observable peptides. Due to low identification scores of some VO
subunits (see above), only subunits c1, a1 and d1 were considered
for stoichiometry estimation. In agreement with the high-
resolution structure35, subunits a1 and d1 show equal abundances
and subunit c1 is present at higher quantities (Supplementary
Data 1). The expected 9-fold abundance of subunit c1 was,
however, not observed. Most likely, similar reasons as described
above for subunit G1/G2 cause these discrepancies for membrane
proteins. Comparing iBAQ values of V1 and VO domains reveals
a higher abundance of VO-subunits suggesting that some V-
ATPase complexes dissociated as reported previously37–39.
Our observations made for the V-ATPase agree well with
previous studies and the recently published structure. We
therefore conclude that stoichiometry estimations can also be
made for other synaptic vesicle proteins. In agreement with
previous studies, we found that Synaptobrevin-2 is the most
abundant protein in synaptic vesicles15,21. Relative abundances of
the other major protein components correlate well with
previously established copy numbers (Supplementary Data 1).
To name a few examples, Synaptobrevin-2, Synaptophysin and
Synaptotagmin-1 displayed relative abundances of approximately
4:2:1 correlating well with previously published copy numbers of
70 (Synaptobrevin-2) versus 31 (Synaptophysin) versus 15
(Synaptotagmin-1)15. Proteins that showed comparable amounts
in previous studies were also equal-abundant in our analyses;
examples are Synaptogyrin and CSP (approximately 2 copies15),
SV2A and VGlu (approximately 15 copies21) as well as Synapsin
and Rab3A (approximately 10 copies15) (Fig. 1d). Importantly,
Syntaxin-1A and SNAP25, which are constituents of the SNARE
complex and infiltrate into the vesicle membrane from the pre-
synaptic membrane during endocytosis, are only low abundant
and have similar iBAQ values suggesting that they enter the
vesicle membrane together in the form of residual or pre-formed
SNARE complex.
Cross-linking reveals inhibited and functionally active states of
the V-ATPase complex in synaptic vesicles. Having identified
the proteins present in typical synaptic vesicle preparations, we
next studied their protein interactions formed in the vesicle
membrane. For this, purified synaptic vesicles were incubated
with Bis(sulfosuccinimidyl) suberate (BS3) cross-linker, which
covalently links primary amines of lysine side chains and protein
N-termini. Following standard protocols40,41, cross-linked pro-
teins were hydrolysed with trypsin and low abundant, cross-
linked peptide pairs were enriched by size-exclusion chromato-
graphy. Fractions containing cross-linked peptides were analysed
by LC-MS/MS followed by database searching and manual
Fig. 1 Proteomic characterisation of synaptic vesicles. a SDS-PAGE of a typical preparation of synaptic vesicles (n > 5). Selected major protein
components are indicated. b Electron microscopy image of purified synaptic vesicles confirming integrity of the vesicles (n= 3). c Relative iBAQ (intensity-
based absolute quantification) of the V1-ATPase. Individual data points, the mean and the standard deviation from five biological replicates are given.
d Relative iBAQ of selected synaptic vesicle proteins. Individual data points, the mean and the standard deviation from five biological replicates are given.
The topology of major vesicle proteins is shown.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21102-w ARTICLE
NATURE COMMUNICATIONS |          (2021) 12:858 | https://doi.org/10.1038/s41467-021-21102-w |www.nature.com/naturecommunications 3
validation of the mass spectra as suggested previously42. To allow
large-scale interactomics and, at the same time, compensate for
computational space during database search, we generated a
synaptic vesicle database containing the top 400 proteins of our
proteome analysis (Supplementary Data 1). Applying this strat-
egy, we validated 175 inter- and 297 intra-molecular cross-links
in four biological replicates (Supplementary Data 3 and Supple-
mentary Fig. 3). Of these, 80 inter- and 199 intra-molecular cross-
links were identified in at least two replicates (Supplementary
Fig. 3). 19 of the inter-molecular cross-links originate from
homo-oligomers which are identified by equal or overlapping
peptide sequences. Example spectra of cross-linked peptides are
shown in Supplementary Fig. 4.
Again, we first reviewed cross-links in the V-ATPase complex.
We identified and validated 22 inter- and 57 intra-molecular
cross-links in ten of the 16 subunits of the V-ATPase including
isoforms G1 and G2. We visualised these cross-links in a network
plot and compared the inter- and intra-molecular interactions
with the high-resolution structure of the V-ATPase complex from
rat brain obtained recently35. All inter-molecular interactions are
observed between protein subunits in close proximity. Specifi-
cally, pronounced cross-linking was observed between the ‘head’
of the V-ATPase (i.e. subunits A and B2) and subunits E1 or D
which contribute to the peripheral and central stalks43. Interac-
tions between peripheral and central stalk subunits E1 and G2 as
well as D and F were also observed. In addition, many cross-links
were identified between the N-terminal, soluble part of
membrane-bound subunit a1 and subunits d1 or G1/2. Intra-
molecular cross-links were mostly observed within subunits A,
B2, E1 and C1 highlighting their accessibility for the BS3 cross-
linker as well as in the N-terminal part of subunit a1 confirming a
high flexibility as suggested previously35,44,45 (Fig. 2a). For
validation of our cross-linking approach, we mapped the
observed cross-links into the available high-resolution structure
of the V-ATPase complex (Fig. 2b). 74 out of 79 cross-links could
successfully be mapped; the missing cross-links were observed in
structural regions which are not included in the high-resolution
structure or subunits missing in the atomic model. The majority
of cross-links (i.e. 50 out of 74) satisfies a cross-linking distance of
≤30 Ȧ (Supplementary Data 4) as expected for the BS3 cross-
linker46. Importantly, long-distance cross-links (>30 Ȧ) are
located in flexible subunits such as the peripheral stalks or
subunit a1 (Supplementary Data 4)47,48. Assuming random cross-
linking of identified cross-linked lysine residues shows a broader
distribution with longer cross-linking distances (Supplementary
Fig. 5) further confirming our approach and validation.
V-ATPase activity is mainly regulated by reversible dissociation
of V1- and VO-domains37–39. Close inspection of the interactions
obtained for subunit a1 reveals cross-links which exclusively
match one of two functional states: an open conformation
representing the active, fully assembled enzyme (Fig. 2c) or a
closed conformation locking the VO-domain (Fig. 2d). In the
open, non-inhibitory conformation, the N-terminal part of
subunit a1 makes contact with the peripheral stalk subunit G1/
G2 thereby allowing enzymatic activity (cross-links G1K21-a1K50
and G2K21-a1K70). In this conformation, interactions between
subunits a1 and d1 are not observed (Fig. 2c). In the closed,
inhibitory conformation, V1 dissociated from the enzyme and the
N-terminal part of a1 folds over the membrane ring. Importantly,
interactions observed for this conformation are formed between
the N-terminus of a1 and subunit d1 as well as the C-terminal,
cytosolic peptide of PRR (residues 324–350) which are both only
accessible when the V1-domain dissociates. Cytosolic PRR
contains only one accessible lysine residue which was found to
cross-link with both a1 (PRRK346-a1K70) and d1 subunits
(PRRK346-d1K239) (Fig. 2d). These cross-links confirm our
observation from the proteomic analysis that the V-ATPase partly
dissociates in synaptic vesicles and the VO-domain is over-
represented as shown by comparably high iBAQ intensities for VO
subunits (see above and Supplementary Data 1).
Interaction networks in synaptic vesicles suggest a central role
for Synaptobrevin-2. We next inspected cross-links obtained for
all synaptic vesicle proteins. For this, inter-molecular cross-links
were visualised in a network plot (Fig. 3). The resulting interac-
tion network shows 56 proteins of which 33 are considered
synaptic vesicle components15. Importantly, most interactions
observed in only one biological replicate include contaminants or
low abundant proteins. Interactions identified in two or more
replicates constitute a network of 76 inter-molecular cross-links
including interactions between Synapsin-1, Synaptogyrin-1,
Synaptobrevin-2, SV2A/B, Rab3A, CSP, Synaptophysin, Synap-
toporin and the AP2 and V-ATPase complexes (Fig. 3). Strik-
ingly, Synaptobrevin-2 was found cross-linked with 32 of the 56
proteins. This includes interactions with specific vesicle proteins
as well as low abundant contaminants suggesting a central role for
Synaptobrevin-2 in complex formation in synaptic vesicle mem-
branes. Interactions between Synaptobrevin-2 and Synapto-
tagmin-1, Synaptogyrin-1 or the vesicular transporters (VGlu1/2)
are only of low count. In addition to interactions with individual
protein subunits, we also identified cross-links between
Synaptobrevin-2 and subunits of the AP2 complex. The AP2
complex associates with synaptic vesicles during clathrin-
mediated endocytosis and retrieval of Synaptobrevin-2 through
different motifs has been described9. We therefore assume that
Synaptobrevin-2 is a cargo of the AP2 complex and a small
population of endocytotic synaptic vesicles was co-purified.
In addition to the dominant, Synaptobrevin-2-centered net-
work, we observed four smaller, ternary protein networks
between Synaptobrevin-2, Synaptophysin and (i) V-ATPase-a1,
(ii) SV2A, (iii) Synapsin-1 or (iv) CSP (Fig. 3). Importantly, all
these ternary networks include Synaptobrevin-2 and Synapto-
physin suggesting a predominant interaction of these two
proteins as reported previously26,29. Multimers (dimers) of
Synaptobrevin-2, Synaptophysin and CSP were also observed.
These were unambiguously identified by overlapping or identical
peptide sequences in the mass spectra of cross-linked peptides
(see Supplementary Fig. 4C for an example). To define the
oligomeric states of Synaptobrevin-2 and Synaptophysin, we
visualised the multimers by immunostaining with specific
antibodies after western blotting of cross-linked synaptic vesicle
proteins. Following this strategy, multimers up to pentamers were
clearly observed for Synaptobrevin-2 while dimers were observed
for Synaptophysin (Supplementary Fig. 6). In addition, both
antibodies stained one additional protein band corresponding in
mass to the cross-linking product of Synaptobrevin-2 and
Synaptophysin further confirming this specific interaction.
Synaptophysin, Synaptobrevin-2 and SV2A interact through
luminal loops. Close inspection of the observed protein inter-
actions formed in our network reveals many interactions that are
accomplished through luminal loops. This mainly concerns cross-
links between SV2A and Synaptophysin but also interactions
between Synaptophysin and Synaptogyrin-1 or Synaptophysin
and Synaptoporin as well as interactions that mediate Synapto-
physin dimerisation (Fig. 4). In few cases, interactions between
cytosolic and luminal loops were observed (for instance between
Synaptobrevin-2 and SV2A). The observation that these luminal
loops are involved in protein interactions in synaptic vesicles
when using a non-membrane permeable cross-linker such as BS3
raises the questions whether integrity of the vesicles and, as a
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consequence, correct protein orientation are affected, or whether
these loops integrate into the vesicle membrane and are therefore
accessible for protein interactions.
To rule out the possibility that vesicles lost integrity during the
purification process (see also Fig. 1b and Supplementary Fig. 1 for
comparison) and to prove that protein orientation is correct, we
made use of Botulinium neurotoxin B (BoNT B) which cleaves
Synaptobrevin-2, the major protein component of synaptic vesicles,
between residues Q76 and F77. The BoNT B cleavage product can
then be identified by a mass shift of the protein band during
western blotting. For this, we titrated the cell supernatant of a BoNT
B producing clostridium bacterial species to aliquots of purified
synaptic vesicles and monitored cleavage of Synaptobrevin-2 by
western blotting using a specific antibody (Supplementary Fig. 7).
Even at low amounts of BoNT B, Synaptobrevin-2 was completely
cleaved without remaining intact Synaptobrevin-2 confirming that
the orientation of proteins in synaptic vesicles was not compro-
mised and that vesicle integrity was maintained.
To address the question whether the luminal loops are indeed
accessible from the cytosol, we then followed a labelling strategy
introduced previously to assess solvent accessible amino acid
residues of proteins and protein complexes49. Using Sulfo-N-
hydroxysuccinimide-acetate (Sulfo-NHS-Acetate) and diethylpyr-
ocarbonate (DEPC), we labelled accessible lysine, histidine, serine,
threonine, tyrosine and cysteine residues50,51 of synaptic vesicle
proteins. Both labelling reagents are non-membrane permeable
Fig. 2 Protein interactions in the V-ATPase complex. a Proteins are shown as coloured bars. The length of the bars corresponds to the protein length.
Cross-links identified within (grey) or between (blue and grey) ATPase subunits are shown in an interaction network. Inter-molecular cross-links identified
in one (grey) or at least two (blue) biological replicates are shown. b 74 out of 78 observed cross-links could be mapped onto the available high-resolution
structure of the V-ATPase complex from rat brain (PDB ID 6VQ6). Cross-linking distances and the number of cross-links obtained from at least one
biological replicate that satisfy these distances are plotted in a histogram. 50 cross-linked amino acid residues showed distances <30 Ȧ (blue). Long-
distance cross-links (red) were mostly observed in flexible protein subunits. Note that cross-links of subunits that are present in multiple copies are only
mapped once. c Inter-molecular cross-links between subunit a1 and subunit G1/G2 supporting the active conformation are shown. The N-terminal domain
of a1 is highlighted in red. A structural cartoon of the V-ATPase is shown for comparison. d Cross-links between subunit a1 and subunits d1 and PRR
supporting the closed, inhibitory conformation are shown. The N-terminal domain of a1 as well as the C-terminal, cytosolic peptide of PRR are highlighted in
red. A structural cartoon of this conformation is shown. A section of the high-resolution structure showing long-distance cross-links supporting the closed
conformation is shown. Note that PRRK346 is missing in the high-resolution structure and cross-links between V-ATPase-a1 and PRR cannot be shown.
Legend to panels (c) and (d): cytosolic, cytosolic part; TMH, transmembrane helix; luminal, luminal part.
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and only modify amino acid residues that are solvent accessible.
Indeed, we found that, in addition to amino acids located in
cytosolic domains, amino acids of the large and luminal loops of
SV2A, Synaptophysin and Synaptoporin are highly modified
(Fig. 4 and Supplementary Data 5). Only one luminal amino acid
(K136) was modified in Synaptogyrin-1, however, the number of
reactive amino acids and tryptic cleavage site is comparably low
in this loop and does not allow identification of more sites. As a
control, we inspected Synaptotagmin-1, which contains a large
cytosolic part (residues 80–421) and a shorter luminal terminus
(residues 1–57), as well as PRR, which contains a short cytosolic
peptide (residues 324–350) and a large luminal domain (residues
18–302). Both proteins contain several potential labelling sites in
their cytosolic and luminal parts. As expected, only cytosolic
amino acids of Synaptotagmin-1 were modified (Supplementary
Data 5). In addition, we observed one DEPC-labelled residue
(K346) in the cytosolic peptide of PRR. Note that the cytosolic
peptide of PRR only contains one tryptic cleavage site and this is
the only residue that can be identified. Modified residues were not
identified in the luminal regions of neither Synatotagmin-1 nor
PRR. Interestingly, by identifying multiple labelled residues in
subunits d1 and a1, our labelling approach further confirms the
presence of the two V-ATPase conformations as observed in our
cross-linking experiments. We therefore conclude that the
labelling approach followed here is applicable to identify
accessible amino acid residues. Accordingly, luminal loops of
SV2A, Synaptophysin, Synaptoporin and Synaptogyrin are
accessible in synaptic vesicle membranes and contribute to
formation of protein interactions.
In detail, amino acids of the large cytosolic loops of SV2A
(residues 1–169 and 356–447) are multiply labelled and cross-link
with intra-molecular lysine residues or lysine residues of
Synaptobrevin-2 and Synaptophysin (Fig. 4a, b). Many of these
interactions are formed between cytosolic and luminal domains
(e.g. SV2AK385-SynaptophysinK83). The large luminal loop of
SV2A (residues 469–598) mainly interacts with the two luminal
loops of Synaptophysin (residues 44–101 and 157–194).
Synaptobrevin-2 also interacts with Synaptophysin; interestingly,
cross-links indicative for these interactions were mostly identified
between the cytosolic lysine residues of Synaptobrein-2 and the
luminal lysine residues of Synaptophysin (Fig. 4a). The one
luminal lysine residue of Synaptogyrin-1 (K136) was found to be
labelled (see above) and cross-linked with luminal lysine residues
of Synaptophysin (Fig. 4b). Studying Synaptophysin in detail, we
found that many amino acids of both luminal loops were modified
by the two labelling reagents. The lysine residues located in these
loops (K83, K163, K173 and K186) heavily cross-link together
(Fig. 4c). Three cross-links (SynaptophysinK83-SynaptophysinK83,
SynaptophysinK186-SynaptophysinK186 and SynaptophysinNterm-
SynaptophysinNterm) contain overlapping peptide sequences and
therefore originate from two copies of the protein indicating
formation of Synaptophysin dimers as also observed from western
blotting (Fig. 4, Supplementary Fig. 6 and Supplementary Data 3).
Note that previously described co-elution and non-covalent gas-
phase association of peptides52 can be excluded for these peptides
as linear and cross-linked peptide pairs have been separated
during the enrichment step (Methods). Cross-links identified
within the same protein but originating from two copies of an
oligomer cannot be distinguished by their mass spectra. However,
intra-molecular cross-links identified in the luminal loops of
Synaptophysin (SynaptophysinK83- SynaptophysinK163/173/186 and
SynaptophysinK186-SynaptophysinK163/173) also support dimerisa-
tion through inter-molecular interactions (Fig. 4c). Note that no
cross-links were identified for the large and flexible N-terminus of
Synaptophysin because a very limited number of lysine residues is
available. In addition, interactions between Synaptophysin and
Synaptoporin (an isoform of Synaptophysin) are also mediated
through the luminal loops (Fig. 4c). Taken together, our results
show that the large and flexible loops of SV2A, Synaptophysin,
Synaptoporin and Synaptogyrin-1 are involved in complex
Fig. 3 Protein interaction network of unstimulated, untreated synaptic vesicles. Synaptic vesicle proteins are shown as coloured bars; contaminants are
shown as grey bars. The length of the bars corresponds to the protein length. The N-terminus is on the left and the C-terminus is on the right side of the
bar. Inter-molecular cross-links identified in one (grey) or at least two (blue) biological replicates are shown. Proteins that are linked through interactions
from only one biological replicate are transparent.
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formation in synaptic vesicles. Their accessibility for labelling and
cross-linking reagents together with identified cross-links between
cytosolic and luminal amino acids suggest an arrangement of these
loops that makes them accessible from the cytosol thereby
allowing protein interactions as well as dimerisation of
Synaptophysin.
Targeting Synaptobrevin-2 in its native environment. The
interaction network obtained from chemical cross-linking sug-
gests that Synaptobrevin-2 plays a central role in complex for-
mation in purified, unstimulated synaptic vesicles used here.
There are two possible scenarios: first, due to its high abundance
in synaptic vesicles15, Synaptobrevin-2 is specifically involved in
many protein interactions, and second, Synaptobrevin-2 non-
specifically contacts many vesicle proteins induced by its high
structural dynamics reported previously53–55. To answer this
question, we followed three approaches: (i) We cleaved
Synaptobrevin-2 with BoNT B (see above) to remove the majority
of the cytosolic domain from the vesicle membrane, (ii) we
engaged Synaptobrevin-2 in SNARE complex formation by
addition of the soluble ΔN-SNARE complex and (iii) we fused
synaptic vesicles with ‘empty’ liposomes to provide a larger
membrane for the vesicle proteins. Subsequently, we chemically
cross-linked the vesicle proteins as described above and investi-
gated protein interactions.
We first studied protein interactions in the absence of
Synaptobrevin-2. For this, we chose a concentration of BoNT B
at which Synaptobrevin-2 was completely cleaved (compare
Supplementary Fig. 7). After successful cleavage of Synaptobre-
vin-2, proteins of synaptic vesicles were cross-linked with BS3
followed by LC-MS/MS analysis of covalently linked tryptic
Fig. 4 Protein interactions identified in flexible, luminal loops. Topology models are shown for Synaptobrevin-2 (red), Synaptoporin/Synaptophysin
(yellow/orange), SV2A (green) and Synaptogyrin-1 (blue). Lysine residues are labelled with residues numbers. Cross-links are indicated by solid and
dashed lines (across the membrane and luminal, red; cytosolic, blue; interactions identified in only one replicate, grey). Chemically labelled amino acid
residues are indicated by stars. Interactions between individual proteins are shown in network plots (rhs). The length of the bars represents the protein
length. The N-terminus is on the left and the C-terminus is on the right side of the bar. Transmembrane helices (TMH) and luminal loops are indicated on
the protein bars. a Interactions and accessible amino acid residues of Synaptobrevin-2, SV2A and Synaptophysin. b Interactions and accessible amino acid
residues of SV2A, Synaptophysin and Synaptogyrin-1. c Interactions and accessible amino acid residues of Synaptophysin and Synaptoporin. Cross-links
that support oligomerisation of Synaptophysin are shown as dashed lines.
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peptides as described above. In total, we identified 216 cross-links
in three biological replicates corresponding to 186 intra-molecular
and 30 inter-molecular cross-links (Supplementary Data 6). Of
these, 159 cross-links were identified in at least two replicates
(Supplementary Fig. 8). Even though the number of identified
cross-links is reduced in this experiment, we obtained a high
number of fragment mass spectra for all individual cross-links
confirming an overall sufficient LC-MS/MS analysis. Most of the
proteins that were found to be cross-linked after BoNT B cleavage
are contaminants (Supplementary Data 6). Nonetheless, several
synaptic vesicle proteins that have been identified in our initial
interaction network are also involved in the interactions identified
in this experiment. These include Synaptobrevin-2, Synaptogyrin-
1, CSP, Synaptophysin, SV2A and SV2B (Supplementary Fig. 9).
As expected, the interaction network shows that the number of
interactions with Synaptobrevin-2 is heavily reduced; only two
cross-links were identified between Synaptobrevin-2 and other
proteins. Importantly, interactions within the V-ATPase complex
are comparable with those identified in untreated synaptic vesicles
(Supplementary Fig. 9) confirming the applicability of cross-
linking to BoNT B treated vesicles. The AP2 complex, on the other
hand, does not make inter-molecular contacts after BoNT B
treatment and only intra-molecular cross-links are observed for
AP2 subunits (Supplementary Data 6). We further observed
interactions between individual synaptic vesicle proteins that have
also been identified before, for instance between Synaptophysin
and V-ATPase-a1, SV2A or Synaptogyrin-1 as well as the CSP
multimer. While we realise that cleavage of Synaptobrevin-2
strongly affects the protein interactions in synaptic vesicles in
general, these protein interactions appear to be stable protein
assemblies in synaptic vesicles.
We next assembled Synaptobrevin-2 in the SNARE complex
and thereby locked the protein in a post-fusion state. For this we
incubated synaptic vesicles with the so-called soluble ΔN-SNARE
complex. The soluble ΔN-SNARE complex contains full-length
SNAP25 (residues 1–206), the SNARE domain of Synatxin-1A
(residues 188–259) as well as a C-terminal peptide of the soluble
domain of Synaptobrevin-2 (residues 49–96). The pre-assembled
complex forms a four-helix bundle as observed for the SNARE
complex during membrane fusion22,56,57. Due to the missing N-
terminus of Synaptobrevin-2, the full-length protein anchored in
the vesicular membrane can assemble into the ΔN-SNARE
complex and, as a consequence, the C-terminal Synaptobrevin-2
peptide dissociates. As Synaptobrevin-2 cannot be cleaved by
BoNT B when assembled in the SNARE complex, we made use of
BoNT B to verify complete engagement of Synaptobrevin-2 in the
SNARE complex (Supplementary Fig. 10A).
We then used chemical cross-linking to identify protein
interactions in synaptic vesicles incubated with the ΔN-SNARE
complex. Due to the high abundance of the three SNARE
proteins, we extended the LC gradient to allow more analysis time
for selection of low abundant cross-linked species. Using this
optimised method, we identified and verified 407 cross-links
corresponding to 260 intra-molecular and 147 inter-molecular
cross-links (Supplementary Data 7). 226 of these cross-links were
identified in at least 2 biological replicates (Supplementary
Fig. 11). The resulting interaction network (Supplementary
Fig. 10b) reveals many interactions between the SNAREs
SNAP25, Syntaxin-1A and Synaptobrevin-2 confirming forma-
tion of the SNARE complex. Note that cross-linked residues of
Synaptobrevin-2 correspond to the soluble, C-terminal peptide
and, therefore, these interactions most likely originate from an
excess of ΔN-SNARE complex which was added to synaptic
vesicles. Again, interactions within the V-ATPase complex are
comparable to those identified above. However, when comparing
interactions of individual proteins observed in this experiment
with those identified in untreated synaptic vesicles, the number of
cross-links between Synaptobrevin-2 and other proteins is
reduced. Instead, we observed many interactions between the
SNARE proteins SNAP25 or Syntaxin-1A and other proteins
including both synaptic vesicle components as well as contami-
nants (Supplementary Fig. 10B). We assume that the SNARE
complex which assembled on vesicular Synaptobrevin-2 now
captures the previously identified cross-links in the crowded
environment of synaptic vesicles. Most frequent are interactions
between the SNAREs and V-ATPase-a1 or Synapsin-1. Several
binary interactions, for instance between Synaptobrevin-2,
Synaptophysin and SV2A as well as cross-links within the
Synaptophysin and Synaptobrevin-2 dimers/multimers are
retained in these experiments suggesting that these proteins form
stable interaction modules. Importantly, for Synaptotagmin-1,
which was underrepresented in complex formation in unstimu-
lated vesicles (Fig. 3), several cross-links with the SNARE
complex were identified. Interactions between Synaptotagmin-1
and the SNARE complex were previously described in primed
pre-fusion complexes58 and might also form in this activated
state. In addition, we observed multiple cross-links between the
SNAREs and Rab1A, Rab3A and Rab39A proteins for which only
intra-molecular cross-links were observed in unstimulated
synaptic vesicles (Supplementary Data 3). As Rab proteins are
involved in trafficking and vesicle recycling59,60, we assume that
these interactions resemble pre- and post-fusion states.
Fusion of synaptic vesicles and liposomes reveals stable protein
interactions. Having targeted Synaptobrevin-2 directly, we next
fused synaptic vesicles with empty liposomes thereby providing
the vesicle proteins with more membrane space. For this, the ΔN-
SNARE complex, i.e. a complex containing full-length SNAP25,
the membrane-anchored Syntaxin-1A SNARE motif (residues
183–288) and the C-terminal peptide of the soluble domain of
Synaptobrevin-2 (residues 49–96), was incorporated into lipo-
somes and incubated with purified synaptic vesicles. Full-length
Synaptobrevin-2 present in the synaptic vesicle membrane
assembles with the ΔN-SNARE complex and thereby induces
membrane fusion. To verify successful membrane fusion, we fol-
lowed the fusion process by monitoring the size of vesicular
species at different time-points using dynamic light scattering. For
better distinction between synaptic vesicles, liposomes and fused
vesicles, we used large ΔN-SNARE-proteoliposomes of 400 nm.
Indeed, we observed a shift of the size distribution to large fused
vesicles after 60–90min (Supplementary Fig. 12). To verify that
only few copies of Synaptobrevin-2 assemble into the SNARE
fusion machinery and the majority of copies is available for
complex formation, we again made use of BoNT B. Complete
cleavage of Synaptobrevin-2 confirmed its availability in fused
synaptic vesicles (Supplementary Fig. 13). Synaptic vesicle proteins
were then cross-linked to study their interactions in this less
crowded environment. We identified and verified 571 cross-links
(440 intra- and 131 inter-molecular; Supplementary Data 8) of
which 278 cross-links were identified in at least two replicates
(Supplementary Fig. 14). Again, cross-links observed for the V-
ATPase complex are comparable to those observed in untreated
vesicles. In contrast to untreated synaptic vesicles, we do not
observe the Synaptobrevin-2-centered interaction network (Fig. 5).
Instead, interactions with specific proteins unveil. These are
involved in smaller networks between Synaptobrevin-2, Synapto-
physin, V-ATPase-a1, SV2A and Synaptoporin. In addition, cross-
links within the Synaptophysin and CPS dimers/multimers or
between the three SNARE proteins were observed. Cross-links of
low frequency were identified between Synaptobrevin-2 and
Synaptotagmin-1 or Rab3A as well as between Synaptophysin and
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Synaptogyrin-1. The absence of the large Synaptobrevin-2 net-
work indicates that most of these interactions were rather
unspecific and mainly form due to the high flexibility and abun-
dance of Synaptobrevin-2. By allowing the proteins to spatially
separate, we identify stable protein interactions which are main-
tained in the more spacious environment of fused synaptic vesicles
and most likely contribute to the proteins’ function.
Discussion
We used chemical cross-linking and MS to uncover protein
interactions in synaptic vesicles. Interactions between
Synaptobrevin-2 and other proteins were remarkably abundant in
purified, unstimulated vesicles suggesting a central role for
Synaptobrevin-2 in complex formation. Inhibited and active
states of the V-ATPase as well as association of the endocytotic
AP2 complex were also observed. By cross-linking differently
treated vesicles, we were able to distinguish unspecific interac-
tions that were formed due to ‘crowding’ conditions in the vesicle
membrane from stable, specific interactions that are retained in a
more spacious membrane environment. These experiments
therefore reveal interaction modules which likely form functional
protein assemblies in synaptic vesicles including interactions of
Synaptobrevin-2, Synaptophysin, SV2A (SV2B) and V-ATPase-
a1 as well as multimers (dimers) of Synaptobrevin-2, CSP and the
two isoforms Synaptophysin and Synaptoporin.
From a technical point of view, chemical cross-linking uncov-
ered, protein interactions in synaptic vesicles in an unbiased
manner, i.e. we were able to identify protein interactions without
the need for specific antibodies or detergent-based protein solu-
bilisation. The latter is of particular importance, as detergent
solubilisation yielded complexes differing in composition29,30
suggesting that the protein complexes of synaptic vesicles are
sensitive towards the detergent used. In addition to simple protein-
protein interactions, our approach delivers detailed insights into
the interactions formed at residue-residue resolution. Note, that the
latter depends on the cross-linking chemistry applied, for instance
the presence of lysine residues when using the BS3 cross-linker. In
addition, one should keep in mind that cross-linking only reveals
binary interactions and an interaction network might contain
Fig. 5 Protein interaction network of synaptic vesicles after fusion with ΔN-SNARE-proteoliposomes. Top schematic: Synaptic vesicles were fused with
ΔN-SNARE-proteoliposomes. During membrane fusion, vesicular Synaptobrevin-2 integrates into the SNARE complex. Fused vesicles provide a more
spacious membrane environment. Network: Synaptic vesicle proteins are shown as coloured bars; contaminants are shown as grey bars. The length of the
bars represents the protein length. The N-terminus is on the left and the C-terminus is on the right side of the bar. Inter-molecular cross-links identified in
one (grey) or at least two (blue) biological replicates are shown. Proteins that are linked through interactions from only one biological replicate are
transparent. A structural cartoon of the V-ATPase is shown for comparison. V-ATPase subunits identified in this interaction network are indicated.
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various protein complexes. The assembly of ternary complexes or
larger assemblies, therefore, has to be confirmed through other
approaches, for instance western blotting of cross-linked complexes
or pull-down experiments. This is particularly true for interaction
networks identified in synaptic vesicles as they pass through dif-
ferent functional states of the vesicle cycle and the assemblies fulfil
the required functions at the various stages. Nonetheless, together
with additional biochemical approaches and the findings of pre-
vious studies, we were able to distinguish different sub-populations
of synaptic vesicles corresponding to the different states of the
synaptic vesicle cycle and to define stable interaction modules. As
mentioned above, unspecific cross-linking might be induced by
proximity of proteins in a crowded environment such as that of
synaptic vesicle membranes. These interactions cannot be dis-
tinguished from specific interactions of tightly bound proteins. To
overcome crowding in the vesicle membrane, we followed different
approaches and, importantly, obtained a protein interaction net-
work in a more spacious membrane environment where cross-
linking due to crowding in the membrane can be neglected. In
summary, we made the following observations:
Protein interactions corresponding to different states or sub-
populations of synaptic vesicles were identified. In particular,
cross-links identified in the V-ATPase complex provided insights
into the regulation of neurotransmitter loading. Previous studies
proposed that one or two V-ATPase complexes are anchored to
the vesicle membrane15,20. Our cross-linking experiments, how-
ever, revealed interactions that exclusively satisfy the fully
assembled V1VO-ATPase or the dissociated VO-ATPase mem-
brane domain. Together with our proteomic analysis, which
showed that VO-ATPase subunits are more abundant than V1-
ATPase subunits, we suppose that either several V-ATPase
complexes incorporate into the vesicle membrane during endo-
cytosis and only a subset of vesicles maintains the V1-domain
after neurotransmitter loading or that a population of synaptic
vesicles without V1-ATPase complexes exists. These findings are
supported by two recent studies showing that, first, V1/VO
assembly depends on the synaptic vesicle cycle and thereby
modulates exocytosis61 and, second, clathrin coated, endocytosed
vesicles maintain their ability to acidify62. Most likely, synaptic
vesicles purified from rat brain synaptosomes contain subsets of
vesicle populations from different states of the synaptic
vesicle cycle.
Apart from the V-ATPase complex, many proteins contribute to
the interaction network of purified and unstimulated synaptic
vesicles. While interactions with contaminants were identified in
only one of four biological replicates, reproducible interactions
dominate the network. However, due to the crowded environment
in synaptic vesicle membranes, these interactions might be con-
sidered unspecific and additional experiments are required to dis-
tinguish specific from unspecific interactions. We therefore
followed different biochemical and biophysical approaches. Speci-
fically, we targeted interactions between Synaptobrevin-2 and ten
synaptic vesicles protein markers as well as the subunits of the AP2
complex. We could show that these interactions are likely attrib-
uted to the high copy number of Synaptobrevin-215,21 as well as its
inherent structural flexibility described previously53–55. Association
of the soluble SNARE complex with Synaptobrevin-2 therefore
induced many interactions between the SNARE complex and
previous interaction partners of Synaptobrevin-2. Following BoNT
B cleavage or fusion of the vesicles with liposomes, only a few of
these interactions were maintained. In fact, cleavage of
Synaptobrevin-2 with BoNT B caused significant disruption of
inter-molecular protein interactions suggesting that Synaptobrevin-
2 represents a hub in the protein assemblies of synaptic vesicles.
The majority of these interactions, however, might be transient as
indicated by their disappearance in a larger vesicle membrane.
The interaction network also revealed dimerisation (multi-
merisation) of Synaptobrevin-2, Synaptophysin and CSP. Multi-
mers of different stoichiometries were described for
Synaptobrevin-2 and Synaptophysin in early studies23,26,63. As
cross-linking MS only reveals binary interactions (see above), our
MS-based approach cannot distinguish between dimers or higher
multimers. However, in agreement with our previous study
combining cross-linking MS and native MS53, we observed
multimers of Synaptobrevin-2 of at least pentamers by western
blotting of cross-linked synaptic vesicles (Supplementary Fig. 6).
For Synaptophysin, a dimeric complex but no higher multimers
were observed. Importantly, one cross-link between Synapto-
physin and Synaptoporin (SynaptophysinK83-SynaptoporinK64)
was identified in four biological replicates indicating that, in
contrast to previous findings63, these two isoforms specifically
and reproducibly interact. This specific cross-link was formed
between two lysine residues located in protein regions of
sequence similarity. The same region was found to mediate dimer
(multimer) formation of Synaptophysin (Fig. 4 and Supplemen-
tary Data 3). We therefore assume that Synaptoporin and
Synaptophysin can form mixed dimers or multimers. However,
even though sequence alignments of the two proteins reveal
similarity in the respective regions64, interactions between
Synaptoporin and interaction partners of Synaptophysin were not
observed suggesting that formation of these complexes is rather
specific. A similar scenario was discovered for the related protein
Synaptogyrin-1; while reproducible cross-links between Synap-
tophysin and Synaptogyrin-1 were identified, interactions
between Synaptogyrin-1 and other proteins are rather infrequent.
However, this might also be attributed to the low number of
cross-linking and tryptic cleavage sites in the Synaptogyrin-1
sequence.
As also reported in previous studies, Synaptobrevin-2 and
Synaptophysin form a stable complex in synaptic vesicles which
was also maintained in a spacious membrane environment after
fusion with liposomes (Figs. 3, 5). The functional role of this
specific interaction was discussed before suggesting, for
instance, a control mechanism for Synaptobrevin-2 to be
released from the Synaptophysin complex and entering the
SNARE complex when required26 or contribution to the fusion
pore by forming a hexameric complex of 2:1 Synaptobrevin-2:
Synaptophysin subcomplexes27. We found that an excess of the
soluble ΔN-SNARE complex as well as addition of BoNT B
induce release of Synaptobrevin-2 from the complex supporting
the proposed control mechanism of a pre-assembled complex
mediated by dynamic interactions that allow disassembly and
possibly reassembly of the two proteins. A weak signal observed
by western blotting together with numerous interactions of
Synaptobrevin-2 with other proteins indicate a relatively low
abundance of this complex; however, its sensitivity against
freezing has been described previously29 and dissociation due to
sample handling cannot be ruled out. The suggested 2:1 stoi-
chiometry of the complex could not be confirmed in our
experiments.
The inter-molecular interactions observed by chemical cross-
linking reveal four ternary sub-networks (Fig. 3) which might or
might not be part of the same protein complex. Importantly,
these smaller networks are in whole or at least in part maintained
after fusion of synaptic vesicles with ‘empty’ liposomes, i.e. these
proteins associate even in a more spacious membrane environ-
ment and, therefore, can be considered specific interaction part-
ners. Other protein interactions, observed in the crowded
membrane of untreated synaptic vesicles, were not identified after
membrane expansion and are rather unspecific. Two early studies
used detergent solubilisation and immunoprecipitation or co-
sedimentation to identify protein complexes of synaptic vesicles.
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Interestingly, one of the previously observed complexes consists
of Synaptobrevin-2, Synaptophysin and the VO-ATPase29 which
together resemble one of the dominant sub-networks observed
here. Other complexes were largely detergent-dependent and
comprised Synaptobrevin-2, Synaptophysin, SV2 and in some
cases Synaptotagmin-1 and/or the V-ATPase30. Again, these
protein components were also linked predominantly in our
interaction network while other major components of synaptic
vesicles (e.g. Synaptotagmin-1) were underrepresented. We
therefore conclude that the majority of interactions in synaptic
vesicle membranes are formed by Synaptobrevin-2, Synapto-
physin/Synaptoporin, SV2A (SV2B) and the V-ATPase complex.
Of these interactors, Synaptophysin/Synaptoporin, Synapto-
gyrin and SV2A/B are integral membrane proteins with four
(Synaptophysin, Synaptoporin, Synaptogyrin) or twelve (SV2A/
B) transmembrane helices connected through several large and
flexible, luminal and cytosolic loops. Surprisingly, close
inspection of the interactions formed between these proteins
revealed extensive cross-linking through both luminal and
cytosolic loops. These observations were confirmed by an
independent labelling experiment employing non-membrane
permeable chemical reagents. In addition, the integrity of pur-
ified synaptic vesicles and the correct protein orientation were
confirmed by additional experiments including electron
microscopy and a BoNT B cleavage assay. Furthermore, the
vesicles used in our experiments proved functionally active as
verified by a fusion assay (Supplementary Fig. 12). Therefore,
the question how these interactions are accomplished remains.
One possibility is the integration of luminal loops in the vesi-
cular membrane making them accessible for non-membrane
permeable cross-linking and labelling reagents. This assumption
is underpinned by two previous findings: First, in phospholipid
bilayers, Synaptophysin forms doughnut-shaped or rosette-like
pores with a central, hollow cavity which accumulates uranyl
salts in negative stain electron microscopy25. Structural simi-
larity with cation channels suggests that large and dynamic
loops might line the inner cavity of Synaptophysin multimers
and are therefore exposed to the cytosol. Second, similar to viral
capsids, which expand or shrink due to their requirements,
synaptic vesicles were found to reversibly increase in size upon
neurotransmitter loading. This increase is likely attributed to
conformational rearrangements of SV2A and possibly other
structurally similar synaptic vesicle proteins65. Our cross-links
suggest that at least a population of synaptic vesicles undergoes
a non-conventional structural rearrangement exposing luminal
domains and making them accessible from the cytosol. This
assumption is strongly supported by interactions between
luminal loops of Synaptophysin and SV2A with cytosolic loops
and Synaptobrevin-2. Cross-linking experiments further suggest
that mixed multimers are formed from these structurally similar
proteins. The functional role of Synaptophysin and related
proteins has not yet been uncovered and suggestions range from
fusion pore formation to regulation of exo- and endocytosis.
Considering our findings, a role for Synaptophysin and SV2A,
and possibly Synaptoporin and Synaptogyrin, in modulating
synaptic vesicle size is hypothesised.
Methods
Purification of synaptic vesicles. Synaptic vesicles were purified from rat brain as
previously described32,33. The rats were kept according to the ethical guidelines
approved by the Office of Veterinary Affairs and Consumer Protection of the city
of Göttingen, Germany (permit number 32.22/Vo). Briefly, brain tissue was
homogenised in 5 mM HEPES-KOH, pH 7.4 containing 320 mM sucrose, 0.2 mM
phenylmethylsulfonyl fluoride, 1 μg/ml pepstatin, 0.1% (v/v) ethanol, 0.1% (v/v)
DMSO. Cell debris was removed by centrifugation and synaptosomes were pel-
leted. Intact synaptosomes were washed and osmotically lysed with ice-cold
water. Synaptic vesicles were pelleted by centrifugation and suspended in 5 mM
HEPES-KOH, pH 7.4 containing 40 mM Sucrose. The suspension was layered on
top of a continuous 0.05-0.8 M sucrose gradient. After centrifugation, synaptic
vesicles were collected at approximately 0.2–0.4 M sucrose and subjected to size-
exclusion chromatography using controlled pore size glass beads for further pur-
ification. Synaptic vesicles were then concentrated by ultracentrifugation. The
protein concentration was determined by UV spectroscopy at 280 nm using a
DeNovix Spectrophotometer DS 11+. The typical protein concentration of purified
synaptic vesicles was 2 μg/μl.
Gel electrophoresis and western blotting. Gel electrophoresis was performed
using the NuPAGE system (Thermo Fisher Scientific) according to the manu-
facturer’s protocols. Briefly, proteins were separated for 35 min at 200 V on 4–12%
Bis–Tris or for 90 min at 125 V on 16% Tricine protein gels. Protein bands were
stained with InstantBlue Coomassie Protein Stain solution (Expedeon). For western
blotting, the proteins were separated by gel electrophoresis as described and
transferred onto a nitrocellulose membrane (Roth) for 3 h at 50 mA. The mem-
brane was blocked for 1 h with PBS/0.02% (v/v) Tween-20 containing 5% (m/v)
milk powder and subsequently washed three times with PBS/0.02% (v/v) Tween-
20. The membrane was incubated with anti-Synaptobrevin-2 clone 69.1 (1:10,000
in PBS/0.02% (v/v) Tween-20; SynapticSystems), anti-VAMP1/2/3 (1:50,000 in
PBS/0.02% (v/v) Tween-20; SynapticSystems) or anti-Synaptophysin-1/2 (1:5,000
in PBS/0.02% (v/v) Tween-20; SynapticSystems) in PBS/0.02% (v/v) Tween-20/1%
(m/v) BSA overnight. After three washing steps, the membrane was incubated with
anti-mouse (for anti-Synaptobrevin-2 clone 69.1 and anti-Synaptophysin-1/2;
1:100,000 in PBS/0.02% (v/v) Tween-20/1% (w/v) BSA) or anti-rabbit (for anti-
VAMP1/2/3; 1:100,000 in PBS/0.02% (v/v) Tween-20/1% (w/v) BSA) secondary
antibody. Proteins were detected using the Pierce ECL Western Blotting Substrate
(Thermo Fisher Scientific). Chemiluminescence was detected using the lumines-
cent image analyzer LAS-4000 (Fujifilm Corporation).
Sample preparation for protein identification. The proteins of synaptic vesicles
were separated by gel electrophoresis as described above. Entire gel lanes were cut
into 23 equally sized gel slices using a gel cutter66. The proteins were then
hydrolysed with trypsin as described previously67. For this, the proteins were first
reduced with dithiothreitol and reduced cysteine residues were then alkylated with
iodoacetamide. The proteins were hydrolysed with trypsin at 37 °C overnight.
Extracted peptides were dried in a vacuum centrifuge and dissolved in 2% (v/v)
acetonitrile/ 0.1% (v/v) formic acid for LC-MS/MS analysis.
Chemical cross-linking. For chemical cross-linking of synaptic vesicle proteins,
synaptic vesicles (protein concentration 2 μg/μg) were incubated with 10 mM BS3
for 1 h at 25 °C and 300 rpm in a thermomixer. The proteins were then precipitated
with 1 vol. ice-cold ethanol and 1/10 vol. 3 M sodium acetate, pH 5.3 at −20 °C.
The protein pellet was washed with 80% (v/v) ice-cold ethanol and dried in a
vacuum centrifuge.
For tryptic hydrolysis, the protein pellet was dissolved in 20 μl 1% (m/v)
RapiGest (Waters) in 25mM ammonium bicarbonate, pH 8.5. Proteins were then
reduced with 20 μl 50 mM dithiothreitol in 25mM ammonium bicarbonate, pH 8.5
for 1 h at 37 °C. Reduced cysteines were alkylated with 20 μl 100mM iodoacetamide
in 25mM ammonium bicarbonate, pH 8.5 for 1 h at 37 °C in the dark. For tryptic
digestion, the concentration of RapiGest was diluted to 0.1% (m/v) with 25mM
ammonium bicarbonate, pH 8.5. Trypsin (Promega) was added at a 1:20 enzyme:
protein ratio followed by incubation at 37 °C overnight. RapiGest was then degraded
by addition of 40 μl of 5% (v/v) trifluoric acid followed by incubation for 2 h at
37 °C. Degraded RapiGest was removed by centrifugation and tryptic peptides were
dried in a vacuum centrifuge.
Cross-linked peptide pairs were enriched by peptide size-exclusion
chromatography on an SuperdexTM peptide 3.2/300 column using an ÄKTA pure
chromatography system (GE Healthcare). For this, the peptides were dissolved in
30% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid followed by isocratic
separation at a flow rate of 50 μl/min. Elution of the peptides was monitored at
280 nm. Fractions of 50 μl were collected. Fractions containing cross-linked peptide
pairs as well as linear peptides were dried in a vacuum centrifuge and dissolved in
2% (v/v) acetonitrile/ 0.1% (v/v) formic acid for LC-MS/MS analysis.
Chemical labelling with sulfo-NHS-acetate and DEPC. For labelling with sulfo-
NHS-acetate, a total protein amount of approximately 30 μg was incubated with 5
and 10 mM sulfo-NHS-acetate for 15 min at 23 °C. The proteins were then pre-
cipitated with 1 vol. ice-cold ethanol and 1/10 vol. 3 M sodium acetate, pH 5.3 at
−20 °C. The protein pellet was washed with 80% (v/v) ice-cold ethanol and dried in
a vacuum centrifuge. The proteins were digested with RapiGest as described for
cross-linked proteins (see above). The peptides were dissolved in 2% (v/v) acet-
onitrile/0.1% (v/v) formic acid for LC-MS/MS analysis.
For labelling with DEPC, a total protein amount of approximately 30 μg was
incubated with 5 and 10 mM DEPC for 10 min at 37 °C. The proteins were then
precipitated with 1 vol. ice-cold ethanol and 1/10 vol. 3 M sodium acetate, pH 5.3
at −20 °C. The protein pellet was washed with 80% (v/v) ice-cold ethanol and dried
in a vacuum centrifuge. The protein pellet was dissolved in 8M urea in 25 mM
Tris-HCl, pH 7.9 followed by incubation for 15 min at room temperature. The
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proteins were reduced with 5 mM dithiothreitol for 30 min at 23 °C followed by
alkylation with 20 mM iodoacetamide for 30 min at 23 °C. The solution was then
diluted with 100 mM ammonium bicarbonate, pH 8.5 to a final concentration of
2M urea. Tryptic hydrolysis was performed at 37 °C overnight (enzyme:protein
1:20). Generated peptides were desalted using ZipTips (Merck Millipore). Briefly,
the C18 material of the ZipTips was equilibrated with 60% (v/v) acetonitrile/0.05%
(v/v) formic acid and adjusted to loading conditions with 0.05% (v/v) formic acid.
The peptides were loaded onto the ZipTips and washed with 0.025% (v/v) FA. The
peptides were eluted with 60% (v/v) ACN/0.1% (v/v) FA. The peptides were dried
in a vacuum centrifuge and dissolved in in 2% (v/v) acetonitrile/ 0.1% (v/v) formic
acid for LC-MS/MS analysis.
LC-MS/MS. Tryptic peptides were separated by nano-flow reversed-phase liquid
chromatography (DionexUltiMate 3000 RSLCnano System, Thermo Scientific; mobile
phase A, 0.1% (v/v) formic acid (FA); mobile phase B, 80% (v/v) acetonitrile (ACN)/
0.1% (v/v) FA) coupled with a Q Exactive Plus Hybrid Quadrupole-Orbitrap mass
spectrometer (Thermo Scientific) or an Orbitrap Fusion Tribrid mass spectrometer
(Thermo Scientific). The peptides were loaded onto a trap column (μ-Precolumn C18
PepMap 100, C18, 300 μm I.D., particle size 5 μm; Thermo Scientific) and separated
with a flow rate of 300 nL/min on an analytical C18 capillary column (50 cm, HPLC
column Acclaim® PepMap 100, C18, 75 μm I.D., particle size 3 μm; Thermo Scien-
tific). For protein identification (in-gel hydrolysis), a gradient of 4–90% (v/v) mobile
phase B over 62min was used. For chemically modified peptides (in-solution
hydrolysis), a gradient of 4–90% (v/v) mobile phase B over 271min was used. Cross-
linked peptides were separated by a gradient of 4–90% (v/v) mobile phase B over 92
min (Q Exactive Plus) or 79min (Orbitrap Fusion). For analysis of cross-linked
peptides of synaptic vesicles incubated with the soluble ΔN SNARE complex, the
gradient was extended to 152min. The gradient was adjusted step-wise for early,
middle and late fractions from peptide size-exclusion chromatography. The peptides
were directly eluted into the mass spectrometer.
Typical mass spectrometric conditions for the Q Exactive Plus mass
spectrometer were: spray voltage, 2.8 kV; capillary temperature, 275 °C; data-
dependent mode. Survey full scans were acquired in the Orbitrap (m/z 350–1600)
at a resolution of 70,000 and an automatic gain control (AGC) target of 3e6. The
20 most intense ions with charge states of 2+ to 7+ were selected for HCD MS/MS
fragmentation in the HCD cell at a resolution of 17,500 and an AGC target of 1e5.
Normalised collision energy was set to 30%. The fixed first mass was 105.0 m/z.
Detection in the HCD cell of previously selected ions was dynamically excluded for
30 s. For cross-linking analysis, doubly charged ions were also excluded. Internal
calibration of the Orbitrap was performed using the lock mass option (lock mass
m/z 445.12002568).
Typical mass spectrometric conditions for the Orbitrap Fusion mass
spectrometer were: spray voltage, 2.0 kV; capillary temperature, 275 °C; data-
dependent mode. Survey full scans were acquired in the Orbitrap (m/z 350–1600)
at a resolution of 120,000 and an AGC target of 5e5. The 20 most intense ions with
charge states of 3+ to 8+ were selected for HCD MS/MS fragmentation in the
HCD cell at a resolution of 30,000 and an AGC target of 5e4. Normalised collision
energy was set to 30%. The fixed first mass was 110.0 m/z. Detection in the HCD
cell of previously selected ions was dynamically excluded for 30 s. Internal
calibration of the Orbitrap was performed using the lock mass option (lock mass
m/z 445.12002568).
Data analysis. For protein identification, raw data were searched against the
uniprot database (taxonomy rattus norvegicus; 31,568 proteins; UniProt proteome
ID: UP000002494; 26 Sep 2018) using MaxQuant v1.6.3.469 with the following
database search settings: enzyme, trypsin; mass accuracy of precursor ions in main
search, 4.5 ppm; mass accuracy of fragment ions in main search, 0.5 Da; number of
allowed missed cleavages, 2; variable modifications, carbamidomethylation of
cysteine and oxidation of methionine; quantification, iBAQ34; FDR, 1%. The
database search results were further processed with Perseus v1.6.2.3. For this,
typical contaminants as well as protein hits with MaxQuant scores <100 and those
which were only identified by their modified peptides were removed from the
results list. The median iBAQ intensities obtained for all proteins from all replicates
were visualised in scatter plots. The 400 most abundant proteins were selected for a
synaptic vesicle protein database.
For identification of modified sites from labelling experiments, raw data were
searched against the generated database using MaxQuant v1.6.3.369. Database
search parameters were: enzyme, trypsin; mass accuracy for precursor ions in main
search, 4.5 ppm; mass accuracy for fragment ions, 0.5 Da; maximum number of
missed cleavages, 4; variable modifications, N-terminal acetylation,
carbamidomethylation of cysteine, oxidation of methionine, acetylation of lysine,
serine, threonine and tyrosine, carboethoxylation of histidine, lysine, cysteine,
serine, threonine and tyrosine including neutral losses from histidine, lysine, serine
and threonine, formyl-carboethoxylation of histidine, di-carboethoxylation of
histidine and urethane-carboethoxylation of histidine including neutral loss
(see ref. 49 for details); FDR, 1%. The ‘match between runs’ option was enabled.
Modified sites with probability scores <0.75 and peptide scores <80 were discarded.
For identification of cross-linked peptides, raw data were searched against the
generated database using pLink v2.3.2 with the following search parameters:
enzyme, trypsin; maximum number of missed cleavages, 2; minimum peptide
mass, 600; maximum peptide mass, 6000; minimum peptide length, 4; maximum
peptide length, 60; mass tolerance for precursor ions, 20 ppm; mass tolerance for
fragment ions, 20 ppm; variable modifications, carbamidomethylation of cysteine
and oxidation of methionine; fragmentation, HCD; cross-linker, BS3 (i.e. reactive
towards lysine residues and protein N-termini); false-discovery rate, 0.05. Results
tables were formatted using the CroCo software70. Potential cross-links were
manually checked for spectral quality. For validation, fragment ion series of at least
4 adjacent fragments should be observed for both peptides with reasonable
intensity. Only cross-links which were observed in at least two replicates and
validated in at least one fragment spectrum were retained. Protein network plots
were generated using XVis71. Cross-links of the V-ATPase complex were mapped
into the atomic model of a high-resolution structured using Xlink Analyzer72 and
UCSF Chimera73.
Botulinum neurotoxin B cleavage. For cleavage with BoNT B, 4 vol. of synaptic
vesicles (2 μg/μl protein concentration) were incubated for 1 h at 37 °C with 1 vol.
of the supernatant of a BoNT B secreting clostridium cell culture. Cleavage was
verified by western blotting using the anti-VAMP1/2/3 antibody.
Purification of the soluble ΔN-SNARE complex and binding to synaptic
vesicles. Proteins of the soluble ΔN-SNARE complex were expressed with an N-
terminal His-tag in E. coli and purified by immobilised metal affinity chromato-
graphy (IMAC) and anion/cation exchange chromatography as described74,75.
Briefly, all proteins were purified through their His-tags by IMAC using Nickel
columns. His-tags were removed by Thrombin cleavage overnight and subsequent
reversed IMAC. The proteins were collected in the flow-through and further
purified by anion (Syntaxin-1A(188-259) and SNAP25(1-206)) or cation
(Synaptobrevin-2(49-96)) exchange chromatography. Note that all cysteine resi-
dues of SNAP25 were mutated to serine residues. Syntaxin-1A(188-259), SNAP25
(1-206) und Synaptobrevin-2(49-96) were incubated at a molar ratio of 1:1:2 for
48 h at 4 °C. The assembled complex was purified by anion exchange chromato-
graphy. An excess of purified ΔN-SNARE complex (approximately 3 copies of the
soluble ΔN-SNARE complex per copy of Synaptobrevin-2) was then added to
synaptic vesicles followed by incubation for 16 h at 4 °C.
Preparation of ΔN-SNARE-proteoliposomes. Syntaxin-1A (183-288), the
cysteine-free variant of SNAP25 (1-206) and Synaptobrevin-2 (49-96) with N-
terminal His-tags were co-expressed in E. Coli and purified as described76. Briefly,
the ΔN-SNARE complex was purified by IMAC using a Nickel column. The His-
tags of the proteins were removed by Thrombin cleavage overnight and subsequent
reversed IMAC. The complex was collected in the flow-through and further pur-
ified by anion exchange chromatography. The purified ΔN-SNARE complex was
stored in 20 mM HEPES containing 200 mM sucrose, 300 mM NaCl and 2% (m/v)
n-Octyl-β-D-glucopyranoside.
Unilamellar liposomes containing DOPC, DOPS and cholesterol at a molar
ratio of 26:4:10 in 20 mM MOPS, pH 7.4 containing 150 mM potassium D-
gluconate were prepared by reverse-phase evaporation77 followed by extrusion with
11 strokes through a polycarbonate membrane with a pore size of 400 nm for
fusion assays and 21 strokes through a polycarbonate membrane with a pore size of
100 nm for cross-linking experiments.
Liposomes were mixed with the ΔN-SNARE complex in n-Octyl-β-D-
glucopyranoside at a molar ratio of 1:500. The detergent was removed by dialysis in
two steps against liposome buffer (see above) using Slide-A-Lyzer cassettes with a
molecular weight cut-off of 2 kDa (Thermo Fisher Scientific, Waltham, MA). The
first dialysis step was performed overnight at 4 °C with 2 g/L of adsorbent beads
(SM-2-Bio-Beads; Bio-Rad, Hercules, CA). The second dialysis step was performed
without adsorbent beads for approximately 4 h at room temperature.
Fusion assay followed by dynamic light scattering. Fusion of isolated synaptic
vesicles with ΔN-SNARE-proteoliposomes was followed by dynamic light scat-
tering using a DynaPro® instrument (Wyatt Technology). First, the size distribu-
tion of freshly isolated synaptic vesicles and ΔN-SNARE-proteoliposomes were
recorded separately. Membrane fusion was then initiated by mixing 25 μl of
synaptic vesicles with 25 μL of 5-times diluted ΔN-SNARE-proteoliposomes in a
black quartz cuvette placed in the DynaPro® instrument. The mixture was incu-
bated at 37 °C and size distributions were recorded at 15, 60 and 90 min. Ten
sequential measurements of 5 s were performed at each time-point using a scat-
tering angle of 90°. The data were processed using the Dynamics V6 software
(Wyatt Technology). The radii and the size distributions were calculated with the
regularisation algorithm as specified in the software.
Electron microscopy. Purified synaptic vesicles were bound to a glow discharged
carbon foil covered grid. After fixation with 1% glutaraldehyde followed by staining
with 1% uranyl acetate, the samples were evaluated at room temperature using a
Talos L120C transmission electron microscope (Thermo Fisher, Eindhoven, The
Netherlands).
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